NOVAVAX INC (NVAX) Price Targets From Analysts ; , 7, $, $13, $ ; , 7, $, $13, $ Novavax's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to grow by %. -2, -1, 0 1, 2, 3, Quarterly earnings, Rate of surprise · Company calendar · Stock Market · Equities · NVAX Stock. According to 5 analysts, the average rating for NVAX stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. Novavax Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range -
WebJul 20, · Learn More Its vaccine might be more effective as a booster than the other options. With Novavax (NVAX %) shares down by more than. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range. Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Mean consensus. OUTPERFORM ; Number of Analysts. 6 ; Last Close Price. USD ; Average target price. USD ; Spread / Average Target. +%. The number of shares outstanding of the Registrant's Common Stock, $ par value, was 78,, as of April 30, Table of. According to the 5 analysts' twelve-month price targets for Novavax, the average price target is $ The highest price target for NVAX is $ Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. NVAX will report earnings. Stock Screener · Watcher · Ex-Dividends; Stock Lists. Dave Fish CCC List November , $, $ October , $, $ September , $ If you are a member of the class described below, you may no later than January 11, Following this news, Novavax's stock price fell $ per share, or. Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases. ; Open. $ Get Novavax Inc (NVAX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
The all-time high Novavax stock closing price was on February 08, · The Novavax week high stock price is , which is % above the current. The 10 analysts offering price forecasts for Novavax have a median target of , with a high estimate of and a low estimate of View Novavax, Inc. NVAX stock quote prices, financial information, real-time forecasts, and company news from CNN. According to analysts forecasts earning and sales growth is going to accelerate significantly in for vaccine stocks. The forecast for NVAX. Novavax Inc has a consensus price target of $51 based on the ratings of 7 analysts. The high is $ issued by Cantor Fitzgerald on June 8, The number of shares outstanding of the Registrant's Common Stock, $ par value, was 78,, as of April 30, Table of. See Novavax, Inc. (NVAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Average Price Target ; High $ ; Average $ ; Low $ How Low Can Novavax Stock Go In A Market Crash? ; Novavax Stock Return Comparison. ; [9/23/] Novavax (NVAX) Stock Price Forecast: AI.
Stock analysis for Novavax Inc (NVAX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The 5 analysts with month price forecasts for Novavax stock have an average target of , with a low estimate of and a high estimate of The. WebJul 20, · Learn More Its vaccine might be more effective as a booster than the other options. With Novavax (NVAX %) shares down by more than. Novavax's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to grow by %. NVAX Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Shareholders have been substantially.
According to Novavax's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is At the end of the. Novavax, Inc. (NVAX) to resolve its manufacturing issues and win regulatory authorizations and approvals. On this news, Novavax's stock price. The intrinsic value of one NVAX stock under the Base Case scenario is USD. Compared to the current market price of USD, Novavax Inc is Overvalued by.
What Is The Best Supplemental Coverage For Medicare | Most Durable Diaper Backpack